thermo fisher file februari day
follow comprehens review file make follow
februari thermo fisher share common stock
outstand y/i averag basic share count
thermo fisher revenu gener unit state remaind
diversifi across number countri thermo fisher includ detail
around acquisit includ patheon thermo fisher repurchas
share total million
million thermo fisher paid quarterli dividend sharehold
consist previous announc
compani rais dividend quarterli unfund portion
thermo fisher guarante benefit decreas million
million thermo fisher backlog increas y/i billion thermo
fisher restructur charg decreas y/i thermo fisher employe
metric obfusc due patheon acquisit thermo fisher provid
detail impact tax reform thermo fisher provid updat long-
term debt oblig new piec litig quarter
compani list number intellectu properti matter thermo fisher list
recent account pronounc file certifi ceo marc
casper cfo stephen williamson februari
quarterli annual ep usd
return equiti ttm
link barclay live interact chart
consensu number thomson reuter
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight thermo fisher market leader
across divers portfolio life scienc tool
diagnost impress global reach across
custom class end market compani
consist track record organ growth capit
deploy manag execut
recommend share core hold exposur
innov healthcar
see upsid thermo fisher target
capit deploy better result
life acquisit upsid case reflect
upsid ebitda billion
thermo fisher exposur econom activ
end market could impact growth
downsid case reflect downsid
ebitda billion
thermo fisher file februari day
follow comprehens review file make follow observ
februari thermo fisher share common stock
outstand y/i averag basic share count
thermo fisher revenu gener unit state
remaind diversifi across number countri notabl china repres
revenu y/i thermo fisher unit state exposur shrunk
thermo fisher includ detail around acquisit includ patheon
august thermo fisher acquir patheon lead global provid
high-qual drug develop deliveri solut pharmaceut
biopharma sector per share cash approxim billion
billion includ assumpt net debt compani financ purchas price
includ repay indebted patheon issuanc debt equiti
acquisit provid entri contract develop manufactur
organ market add complementari servic compani exist
portfolio patheon revenu total billion year end octob
patheon includ compani laboratori product servic
februari thermo fisher acquir finess solut million net
cash acquir finess develop control autom softwar
bioproduct increas thermo fisher scale fast grow market
compani total revenu roughli million finess includ
march compani acquir informat provid cloud-bas
platform support scientif data manag revenu million
acquir compani report thermo fisher analyt
compani acquir within specialti diagnost segment north
america-bas molecular diagnost compani offer qpcr test transplant
commun within analyt instrument segment provid desktop
scan electron microscopi solut manufactur volatil organ
compound monitor instrument integr system aggreg purchas
price million
thermo fisher repurchas share total million
million compani million remain
share repurchas author
share repurchas quarter total million
thermo fisher paid quarterli dividend sharehold consist
previous announc compani rais
dividend quarterli
quarterperiodsharesavg pricetot repurchasedmax amount programstot total barclay thermo fisher scientif inc
unfund portion thermo fisher guarante benefit decreas
million million project benefit oblig relat
us pension contribut plan estim rang million
thermo fisher backlog increas y/i billion believ acquisit
patheon contribut increas backlog thermo fisher believ virtual
backlog fill
thermo fisher restructur charg decreas y/i thermo fisher
record million restructur charg exclud gain sinc thermo
fisher written billion equiti
project benefit valu barclay thermo fisher scientif inc
histor restructur charg segment million
thermo fisher employe metric obfusc due patheon acquisit
revenu ebitda per employe declin y/i cffo per employe flat
y/i like acquisit patheon contribut softer
result note past five year revenu per employe declin
ebitda cffo improv respect
life ex-gainscost ex-gainscost ex-gainscost prod ex-gainscost ex-gainscost ex-gainscost barclay thermo fisher scientif inc
thermo fisher provid detail impact tax reform compani
recogn billion incom tax charg year end decemb relat
transit tax compani also remeasur net defer tax balanc
affect tax act reduct corpor incom tax rate result
billion incom tax benefit year end decemb although net
million charg repres compani believ reason estim
impact tax act compon net charg provision may chang
exampl estim may impact need analysi futur
clarif guidanc regard avail tax account method elect
earn profit comput state tax conform feder tax chang
thermo fisher provid updat long-term debt oblig
credit facil juli compani replac exist revolv credit
facil new facil bank group provid billion
unsecur multi-curr revolv credit facil expir juli
agreement call interest either libor-bas rate euribor-bas rate
fund drawn euro rate base prime lend rate agent bank
compani option agreement contain affirm neg financi
coven event default customari financ type coven
revolv credit facil facil includ consolid leverag ratio total
debt-to-consolid ebitda consolid interest coverag ratio consolid
ebitda consolid interest expens term defin facil
specif compani agre long lender commit
facil letter credit outstand facil loan
oblig outstand facil maintain maximum
consolid leverag ratio third fourth quarter
maximum ratio step first second quarter
step third quarter thereaft
compani also agre long lender commit
facil letter credit outstand facil loan
oblig outstand facil maintain minimum consolid
interest coverag ratio last day fiscal quarter
decemb borrow outstand facil although
avail capac reduc approxim million result
outstand letter credit
commerci paper compani commerci paper program pursuant
may issu sell unsecur short-term promissori note
program matur may exceed day date issu cp
note issu privat placement basi customari term commerci
paper market redeem prior matur subject voluntari
prepay euro program matur may exceed day may
denomin euro dollar japanes yen british pound sterl swiss franc
canadian dollar currenc program cp note issu
discount par premium par case neg interest rate
altern sold par bear vari interest rate fix float basi
decemb outstand borrow program
million weight averag remain period matur day
classifi short-term oblig accompani balanc sheet
senior note fund patheon acquisit compani issu float rate
senior note due subsidiari independ function
financ activ float rate senior note due fulli
uncondit guarante compani subsidiari compani
guarante oblig third quarter compani
issu float rate senior note due senior note due
senior note due senior note due
senior note due senior note due
interest rate swap arrang compani termin certain fix
float rate swap arrang termin swap account fair
valu hedg result termin arrang compani receiv
million exclud accru interest cash includ financ
activ net statement cash flow proce record part
carri valu underli debt amort reduct interest
expens remain term respect debt instrument subsequ
compani enter new swap arrang includ tabl
compani enter libor-bas interest rate swap arrang
variou bank sever outstand senior note aggreg amount
swap equal princip amount note payment date
swap coincid interest payment date note swap contract
provid compani pay variabl interest rate receiv fix rate
variabl interest rate reset monthli swap account fair valu
hedg note tabl summar swap
notesnot amount million pay rater senior note due libor senior note due libor senior note due libor barclay thermo fisher scientif inc
new piec litig quarter compani list
number intellectu properti matter
june yale univers file complaint
unit state district court district connecticut
plaintiff alleg patent infring applera label dna termin product
use dna sequenc fragment analysi plaintiff sought damag
alleg will infring attorney fee cost prejudg interest injunct
relief novemb juri award damag million prejudg
interest million also grant million judgment interest
accru march us court appeal vacat
judgement return case district court proceed
februari district court grant compani motion summari judgment
non-infring enter judgment favor enzo appeal decis
ratecommerci senior note due rate senior note due senior note due senior note due rate senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due senior note due borrow valu hedg account premium discount debt borrow carri short-term oblig current barclay thermo fisher scientif inc
feder circuit march august feder circuit affirm
district court judgment compani product issu litig
infring enzo patent enzo right appeal laps fourth quarter
compani revers accrual reduct restructur cost
accompani incom statement
wissenschaften ev file complaint life technolog unit state
district court western district wisconsin plaintiff alleg patent
infring sale use appli biosystem short tandem repeat dna
identif product outsid scope licens agreement plaintiff
sought damag alleg will infring attorney fee cost prejudg
interest injunct relief although juri initi found will infring
assess damag million district court subsequ overturn
verdict ground plaintiff fail prove infring district
court enter judgment favor life technolog case current
appeal unit state court appeal feder circuit million
award accru life technolog decemb court
appeal issu decis invalid four plaintiff patent find
infring life technolog remain fifth patent court appeal
also order new trial damag district court petit
 suprem court seek review court appeal judgment grant
june case stay district court pend outcom
suprem court review februari suprem court issu
decis revers court appeal judgment remand case
court appeal proceed view suprem court legal
interpret patent law statut question novemb court
appeal issu decis hold promega entitl recov
damag affirm district court grant judgment favor life
technolog denial promega motion new trial court appeal
deni promega petit rehear februari promega
day therefrom file petit suprem court seek review
court appeal decis compani maintain million accrual
pend conclus matter
june unison strateg ip file complaint
unit state district court southern district california alleg patent
infring life technolog suppli chain manag system softwar
oper product suppli center instal custom site plaintiff seek
damag alleg will infring attorney fee cost injunct relief
august unison file appeal decis patent trial
appeal board found challeng patent claim invalid
may februari academi allergi asthma primari
unit biolog llc d/b/a unit allergi servic provid on-sit
servic physician deliveri test treatment allergi file
complaint phadia inc subsidiari compani thermo fisher
scientif inc respect unit state district court western district
texa plaintiff alleg variou claim anticompetit activ violat
anti-trust law tortiou interfer contract exist prospect
busi relat civil conspiraci litig settl decemb
payment immateri amount compani
februari fasb issu new guidanc allow reclassif
accumul comprehens incom aoci retain earn certain tax
effect item within aoci result tax cut job act tax
act guidanc effect earli adopt permit
compani may choos record reclassif period adopt
retrospect compani current evalu time method
decemb sec staff issu guidanc address applic
account guidanc situat registr necessari
inform avail prepar analyz includ comput reason
detail complet account certain incom tax effect tax act enact
decemb discuss note compani report
provision amount certain incom tax effect tax act reason
estim determin account impact may chang base
analysi regard amount composit compani histor
foreign earn futur issuanc interpret regul adjust
provision amount identifi measur period may
decemb includ adjust benefit provis
incom tax period amount determin
august fasb issu new guidanc simplifi applic hedg
account guidanc among thing new guidanc permit hedg
strategi qualifi hedg account allow addit time perform initi
assess hedg effect permit qualit effect test
certain hedg initi qualif compani adopt guidanc
januari adopt guidanc expect materi
impact compani consolid financi statement
march fasb issu new guidanc intend improv present
net period pension cost net period postretir benefit cost new
guidanc requir servic cost compon net period cost report
line item employe compens cost compon
net period cost report incom statement oper incom
guidanc effect compani adopt guidanc
expect materi impact compani consolid financi
januari fasb issu new guidanc elimin requir
calcul impli fair valu goodwil measur goodwil impair charg
instead new guidanc requir entiti record impair charg base
excess report unit carri amount fair valu guidanc
effect compani earli adopt permit adopt
guidanc materi impact compani consolid financi
januari fasb issu new guidanc clarifi definit busi
provid criteria determin integr set asset activ
defin busi new guidanc requir integr set defin
asset busi substanti fair valu gross asset
acquir dispos concentr singl identifi asset group similar
identifi asset guidanc effect compani adopt
guidanc expect materi impact compani
octob fasb issu new guidanc elimin deferr tax
effect intra-ent asset transfer guidanc effect compani
impact guidanc depend extent futur asset transfer
usual occur connect plan around acquisit busi
structur activ adopt guidanc expect materi
impact compani consolid financi statement
march fasb issu new guidanc affect account stock-
base compens new guidanc simplifi account share-bas
payment transact includ incom tax consequ classif award
either equiti liabil classif statement cash flow
compani adopt guidanc januari appli chang
statement cash flow retrospect adopt guidanc decreas
compani tax provis million increas dilut earn per
share period impact futur period depend
upon chang compani stock price volum employe stock option
exercis time service- performance-bas restrict unit vest
februari fasb issu new guidanc requir lesse record
leas balanc sheet leas liabil initi measur present valu
futur leas payment correspond right-of-us asset new guidanc
also set forth new disclosur requir relat leas compani plan
